Medical Imaging Corp. (MEDD) Stock

About Medical Imaging Corp.

Medical Imaging Corp. (MEDD), operating through its various subsidiaries across North America, provides a comprehensive array of diagnostic imaging solutions for a diverse clientele, including individual patients, healthcare facilities, workers' compensation organizations, and insurance carriers. The company also specializes in teleradiology, offering remote analysis and reporting for medical scans. Its robust service portfolio encompasses modalities such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), ultrasound, nuclear medicine, digital mammography, X-ray, and bone mineral densitometry. As of the end of 2017, its physical operations included a standalone diagnostic imaging center in Pottsville, Pennsylvania, in addition to three diagnostic facilities located throughout Florida. Established in 2000 and headquartered in Las Vegas, Nevada, the enterprise adopted its current name, Medical Imaging Corp., in July 2014, having previously operated as Diagnostic Imaging International Corp.

Medical Imaging Corp. (MEDD) stock trades at $0.00 with a market capitalization of $95729. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.01. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Medical Imaging Corp. generates a return on equity (ROE) of 60.00% — well above the market average, a sign of a high-quality business, return on capital employed of 21.36%, an operating margin of -14.29%, a net profit margin of -42.86%.

Official website: www.medimagingcorp.com